Does Medicaid Pay For Resmetirom Tablet In Nevada? Full Coverage Breakdown
Resmetirom, marketed under the brand name Rezdiffra, is a new prescription treatment developed for patients with nonalcoholic steatohepatitis (NASH) who do not have cirrhosis. As the first FDA-approved therapy specifically designed to target liver fibrosis in NASH patients, Resmetirom represents a critical breakthrough in liver disease treatment. However, its high cost and limited insurance availability…